Living in vicinity of fast food outlets tied to higher risk of developing diabetes: JAMA MD Editorial Team1 Nov 2021 9:00 AM ISTLiving in neighborhoods with higher availability of fast-food outlets across all regions of the United States is associated with higher subsequent...
Dapagliflozin improves kidney function in patients with diabetes patients with CKD: Lancet Medha Baranwal1 Nov 2021 9:00 AM ISTDelhi: Dapagliflozin compared with placebo significantly improves the rate of decline in kidney function in patients with chronic kidney disease...
Vitamin D levels associated with improved islet function in type 2 diabetes patients: Study Dr. Shravani Dali30 Oct 2021 7:03 PM ISTChina: A recent study published in the BMC Endocrine Disorders suggested a positive relationship between the vitamin D status and modified HOMA-β....
Type 2 diabetes: SGLT2 inhibitors not tied to fracture risk in older adults, finds study Medha Baranwal30 Oct 2021 10:00 AM ISTBoston, MA: A recent study in the JAMA Network Open has shown that the initiation of SGLT2 inhibitors does not appear to increase the risk of fracture...
Health Bulletin 28/October/2021 Roshni Dhar28 Oct 2021 10:52 AM ISTHere are Top Health Stories of the dayNMC to do away with positions of Tutor, Demonstrator, Registrar, bring them all under Senior Resident...
Overt hypogonadism a CVD risk factor for male diabetes patients: study Dr. Shravani Dali27 Oct 2021 10:00 AM ISTOvert hypogonadism is cardiovascular disease (CVD) risk factor for males in type-2 diabetes mellitus (T2DM), according to a study published in...
Glucokinase activators effectively manage PP blood sugar in diabetes but with hypoglycemia risk: Study Medha Baranwal27 Oct 2021 9:00 AM ISTChina: A recent study in the journal Medicine has shown glucokinase activators (GKAs) to be more effective than placebo for postprandial blood sugar...
Medical Bulletin 26/October/2021 Dr. Nandita Mohan26 Oct 2021 4:31 PM ISTHere are the Top Medical Stories of the dayShockwave therapy- treatment for chronic prostatitisExtracorporeal shock wave therapy (ESWT) is an...
Glenmark launches Remogliflozin, Vildagliptin, Metformin FDC at Rs 16.50 per tablet Ruchika Sharma26 Oct 2021 1:35 PM ISTMumbai: Drugmaker, Glenmark Pharmaceuticals Limited, today announced that the company has launched a fixed dose combination (FDC) of its novel, patent...
Increased whole grain consumption reduces diabetes incidence and associated economic burden: Study Hina Zahid26 Oct 2021 9:45 AM ISTIncreased consumption of whole grain foods could significantly reduce the incidence of type 2 diabetes and the costs associated with its treatment in...
Estimation of Insulin resistance may predict risk of first stroke in diabetes patients: Study Medha Baranwal26 Oct 2021 9:00 AM ISTSweden:Estimated glucose disposal rate (eGDR) is a validated clinical tool for estimating insulin sensitivity in type 1 diabetes.Insulin resistance...
Empagliflozin reduces insulin initiation in patients with diabetes and CVD: EMPA-REG OUTCOME trial Medha Baranwal25 Oct 2021 9:30 AM ISTUSA: Empagliflozin markedly and durably delays insulin initiation and substantial increases in insulin dose in patients with type 2 diabetes and...
